Trace elements and cardiovascular disease

Forum of Nutrition

Volumn 54, Issue , 1998, Pages 127-140

  Strain, J J ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; COPPER; OXIDIZING AGENT; TRACE ELEMENT;

ANIMAL; ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASE; HUMAN; PHYSIOLOGY; REVIEW; THROMBOSIS;

ANIMALS; ANTIOXIDANTS; ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASES; COPPER; HUMANS; OXIDANTS; THROMBOSIS; TRACE ELEMENTS;

EID: 54249130862     PISSN: 16600347     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000059453     Document Type: Article

References (104)

1. Horovitz CT: Is the major part of the periodic system really essential for life? J Trace Elem Electrolytes Health Dis 1989;2:135-144.
2. Klevay LM: Coronary heart disease: The zinc/copper hypothesis. Am J Clin Nutr 1975;28:764-774.
3. Klevay LM: Ischemic heart disease: Updating the zinc/copper hypothesis; in Naito HK (ed): Nutrition and Heart Disease. New York, SP Medical & Scientific Books, 1982, pp 61-67.
4. Klevay LM: Ischemic heart disease: Toward a unified theory; in Lei KY, Carr TP (eds): Role of Copper in Lipid Metabolism. Boca Raton, CRC Press, 1990, pp 233-267.
5. Klevay LM: Ischemic heart disease: Nutrition or pharmacotherapy? J Trace Elem Electrolytes Health Dis 1993;7:63-69.
6. Klevay LM: Elements of ischemic heart disease. Perspect Biol Med 1997;20:186-192.
7. Klevay LM: The role of copper, zinc, and other chemical elements in ischemic heart disease; in Rennert OM, Chan W-Y (eds): Metabolism of Trace Metals in Man. Boca Raton, CRC Press, 1984, vol 1, pp 129-157.
8. Klevay LM: Elements of atherosclerosis; in Reis MF, Pereira Miguel JM, Machado AASC, Abdulla M (eds): Trace Elements in Medicine, Health and Atherosclerosis. London, Smith-Gordon, 1996, pp 11-14.
9. Wolber KA: Thyrotoxicosis and the heart. N Engl J Med 1992;327:94-98.
10. Klausen IC, Nielsen FE, Hegedüs L, Gerdes LU, Charles P, Faergeman O: Treatment of hypothyroidism reduces low-density lipoproteins but not lipoprotein (a). Metabolism 1992;41:911-914.
11. Arem R, Wiener GJ, Kaplan SO, Kim H-S, Reichlin S, Kaplan MM: Reduced tissue thyroid hormone levels in fatal illness. Metabolism 1993;42:1102-1108.
12. Sullivan JL: Iron and the sex difference in heart disease risk. Lancet 1981;i:1293-1294.
13. Salonen JT, Nyyssönen K, Korpela H, Tuomilehto J, Seppänen R, Salonen R: High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992;86:803-811.
14. Sempos CT, Looker AC, Gillum RF: Iron and heart disease: The epidemiologic data. Nutr Rev 1996;54:73-84.
15. Oshaug A, Bugge KH, Bjonnes CH, Borch-Iohnsen B, Neslein I-L: Associations between serum ferritin and cardiovascular risk factors in healthy young men: A cross-sectional study. Eur J Clin Nutr 1995;49:430-438.
16. Strain JJ: Putative role of dietary trace elements in coronary heart disease and cancer. Br J Biomed Sci 1994;51:241-251.
17. Filipe PM, Fernandes AC, Manso CF: Effects of zinc on copper-induced and spontaneous lipid peroxidation. Biol Trace Elem Res 1995;47:51-56.
18. Cabré M, Folch J, Giménez A, Matas C, Parés A, Caballeria J, Paternain JL, Rodes J, Joven J, Camps J: Influence of zinc intake on hepatic lipid peroxidation and metallothioneins in alcoholic rats: Relationship to collagen synthesis. Int J Vitam Nutr Res 1995;65:45-50.
19. Faure P, Benhamou PY, Perard A, Halimi S, Roussel AM: Lipid peroxidation in insulin-dependent diabetic patients with early retina degenerative lesions: Effects of an oral zinc supplementation. Eur J Clin Nutr 1995;49:282-288.
20. Bray TM, Bettger WJ: The physiological role of zinc as an antioxidant. Free Radic Biol Med 1990; 8:281-291.
21. Xu Z, Bray TM: Electron spin resonance spin trapping studies of the effects of dietary zinc deficiency on free radical production in vitro and in vivo under acute oxidative stress. J Nutr Biochem 1994; 5:490-494.
22. Sato M, Bremner I: Oxygen free radicals and metallothionein. Free Radic Biol Med 1993;14:325-337.
23. Olin KL, Golub MS, Gershwin ME, Hendricks AG, Lonnerdale B, Keen CL: Extracellular superoxide dismutase activity is affected by dietary zinc intake in nonhuman primate and rodent models. Am J Clin Nutr 1995;61:1263-1267.
24. Gatto LM, Samman S: The effect of zinc supplementation on plasma lipids and low-density lipoprotein oxidation in males. Free Radic Biol Med 1995;19:517-521.
25. Black MR, Medeiros DM, Brunett E, Welk R: Zinc supplements and serum lipids in young adult white males. Am J Clin Nutr 1988;47:970-975.
26. Abdallah SM, Samman S: The effect of increasing dietary zinc on the activity of superoxide dismutase and zinc concentration in erythrocytes of healthy female subjects. Eur J Clin Nutr 1993; 47:327-332.
27. Rajagopalan KV: Molybdenum: An essential trace element in human nutrition. Annu Rev Nutr 1988;8:401-427.
28. Bluhm G: Selenium and cardiovascular disease. Trace Elem Med 1990;7:139-145.
29. Nielsen FH: Nutritional significance of the ultratrace elements. Nutr Rev 1988;46:337-341.
30. Mertz W: Trace minerals and atherosclerosis. Fed Proc 1982;41:2807-2812.
31. Strain JJ: Disturbances of micronutrient and antioxidant status in diabetes. Proc Nutr Soc 1991; 50:591-604.
32. Brichard SM, Lederer J, Henquin JC: The insulin-like properties of vanadium: A curiosity or a perspective for the treatment of diabetes? Diabète Métab 1991;17:435-440.
33. Cohen N, Halberstam M, Shlimovich P, Chang CJ, Shamoon H, Rosetti L: Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1995;95:2501-2509.
34. Tarugi P, Calandra S, Borella P, Vivoli GF: Heavy metals and experimental atherosclerosis: Effect of lead intoxication on rabbit plasma lipoproteins. Atherosclerosis 1982;45:221-234.
35. Hass GM, Brown DVL, Eisenstein R, Hemmens A: Relations between lead poisoning in rabbit and man. Am J Pathol 1964;45:691-698.
36. Mylroie AA, Boseman A, Kyle J: Metabolic interactions between lead and copper in rats ingesting lead acetate. Biol Trace Elem Res 1986;9:221-231.
37. Lawton LJ, Donaldson WE: Lead-induced tissue fatty acid alterations and lipid peroxidation. Biol Trace Elem Res 1991;28:83-97.
38. Bordas E, Gabor S: Die cholesterinämie unter der Auswirkung der assoziierten Verabreichung von Kadmium: Kupfer und Cholesterin. Rev Roumaine Biochim 1982;1:3-7.
39. Perry HM Jr, Erlanger WM: Effect of a second metal on cadmium-induced hypertension; in Hemphill DD (ed): Trace Substances in Environmental Health. XI. Columbia, University of Missouri, 1977, pp 280-288.
40. Reicks M, Rader JJ: Effects of dietary tin and copper on rat hepatocellular antioxidant protection. Proc Soc Exp Biol Med 1990;195:123-128.
41. Klevay LM: Interactions of copper and zinc in cardiovascular disease. Ann NY Acad Sci 1980; 355:140-151.
42. Nielsen FH: Nickel; in Mertz W (ed): Trace Elements in Human and Animal Nutrition. San Diego, Academic Press, 1987, vol 1, pp 245-273.
43. Spielvogel BF, Wojnowich L, Das MK, McPhail AT, Hargrave KD: Boron analogues of amino acids: Synthesis and biological activity of boron analogues of betaine. J Am Chem Soc 1976;98: 5702-5706.
44. Nielsen FH: Nutritional requirements for boron, silicon, vanadium, nickel, and arsenic: Current knowledge and speculation. FASEB J 1991;5:2661-2667.
45. Carlisle EM: Silicon. Nutr Rev 1975;33:257-261.
46. Emerick RJ, Kayongo-Male H: Silicon facilitation of copper utilization in the rat. Nutr Biochem 1990;1:487-192.
47. Chen C-J, Wu M-M, Lee S-S, Wang J-D, Cheng S-H, Wu H-Y: Atherogenicity and carcinogenicity of high-arsenic artesian well water: Multiple risk factors and related malignant neoplasms of blackfoot disease. Arteriosclerosis 1988;8:452-460.
48. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL: Beyond cholesterol: Modification of low-density lipoprotein that increases its atherogenicity. N Engl J Med 1989;320:915-924.
49. Esterbauer H, Gebicki J, Puhl H, Jürgens G: The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 1992;13:341-390.
50. KoK FJ, Van Duiyn M, Hofman A, Van der Voet OB, De Wolff FA, Paays CH, Valkenburg HA: Serum copper and zinc and the risk of death from cancer and cardiovascular disease. Am J Epidemiol 1988;128:352-359.
51. Reunanen A, Kneket P, Aran R-K: Serum ceruloplasmin level and the risk of myocardial infarction and stroke. Am J Epidemiol 1992;136:1082-1090.
52. Salonen JT, Salonen R, Korpela H, Suntioninen S, Tuomileho J: Serum copper and the risks of acute myocardial infarction: A prospective population study in men in eastern Finland. Am J Epidemiol 1991;134:268-276.
53. Salonen JT, Salonen R, Seppären K, Kantola M, Suntioninen S, Korpela H: Interactions of serum copper selenium, and low density lipoprotein cholesterol in atherogenesis. Br J Med 1991;302: 756-760.
54. Reunanen A, Knekt P, Marniemi J, Maki J, Maatela J, Aromaa A: Serum calcium, magnesium, copper and zinc and risk of cardiovascular death. Eur J Clin Nutr 1996;50:431-437.
55. Craig WY, Poulin SE, Palomaki GE, Neveurx LM, Ritchie RF, Ledue TB: Oxidation-related analytes and lipid and lipoprotein concentrations in healthy subject. Arterioscler Thromb Vase Biol 1995;15:733-739.
56. Cousins RJ: Absorption, transport, and hepatic metabolism of copper and zinc: Special reference to metallothionein and ceruloplasmin. Physiol Rev 1985;65:238-309.
57. Di Silvestro RA: Influence of dietary copper, copper injections and inflammation on rat serum ceruloplasmin activity levels. Nutr Res 1990;10:355-358.
58. Wagner TL, DiSilvestro RA, Medeiros DM: Marginal copper intake and inflammation effects on copper enzyme activities in rats. J Trace Elem Exp Med 1995;8:41-46.
59. Arnaud J: Copper. Int J Vitam Nutr Res 1994;63:308-311.
60. Olivares M, Ulay R: Copper as an essential nutrient. 1996;63:791S-796S.
61. Milne DB, Nielsen FH : Effects of a diet low in copper on copper-status indicators in postmenopausal women. Am J Clin Nutr 1996;63:358-364.
62. Saenko EL, Yaropolov AI, Harris ED: Biological function of ceruloplasmin expressed through copper-binding sites and a cellular receptor. J Trace Elem Exp Med 1994;7:69-88.
63. Krsek-Staples JA, Webester RO: Ceruloplasmin inhibits carbonyl formation in endogenous cell proteins. Free Radic Biol Med 1993;14:115-125.
64. Ehrenwald E, Chisolm GM, Fox PL: Intact human ceruloplasmin oxidatively modifies low density lipoprotein. J Clin Invest 1994;93:1493-1501.
65. Ehrenwald E, Fox PL: Role of endogenous ceruloplasmin in low density lipoprotein oxidation in human U937 monocytic cells. J Clin Invest 1996;97:884-890.
66. Ogihara H, Ogihara T, Miki M, Yasuda H, Mino M: Plasma copper and antioxidant status in Wilson's disease. Pediatr Res 1995;37:219-226.
67. Hamada T: Antioxidant and prooxidant roles of copper in Tween 20-induced hemolysis of hamster and pig erythrocytes containing marginal vitamin E. Experientia 1995;51:572-576.
68. Sorenson JRJ: Copper complexes offer a physiological approach to treatment of chronic diseases; in Ellis GP, West GB (eds): Progress in Medical Chemistry. New York, Elsevier, pp 437-568.
69. Johnson MA, Fischer JG, Kays SE: Is copper an antioxidant nutrient? Crit Rev Food Sci Nutr 1992;32:1-31.
70. Allen KGD, Klevay LM: Copper: An antioxidant nutrient for cardiovascular health. Curr Opin Lipidol 1994;5:22-28.
71. Strain JJ: Newer aspects of micronutrients in chronic disease: Copper. Proc Nutr Soc 1994;53: 583-598.
72. Prohaska J: Biochemical changes in copper deficiency. J Nutr Biochem 1990;1:452-461.
73. Sohal RS: The free radical hypothesis of aging: An appraisal of the current status. Aging Clin Exp Res 1995;5:3-17.
74. Sohal RS, Sohal BH, Orr WC: Mitochondrial superoxide and hydrogen peroxide generation, protein oxidative damage, and longevity in different species of flies. Free Radic Biol Med 1995;19:499-504.
75. Warner HR: Superoxide dismutase, aging, and degenerative disease. Free Radic Biol Med 1994;17: 249-258.
76. Lai C-C, Huang W-H, Askari A, Wang Y, Sarvazyan N, Klevay LM, Chiu TH: Differential regulation of superoxide dismutase in copper-deficient rat organs. Free Radic Biol Med 1994;16:613-620.
77. Lai C-C, Huang W-H, Askari A, Klevay LM, Chiu TD: Expression of glutathione peroxidase and catalase in copper-deficient rat liver and heart. J Nutr Biochem 1995;6:256-262.
78. Lai C-C, Huang W-H, Klevay LM, Gunning WT III, Chiu TH: Antioxidant enzyme gene transcription in copper-deficient rat liver. Free Radic Biol Med 1996;21:233-240.
79. Prohaska R, Sunde RA, Zinn KR: Livers from copper-deficient rats have lower glutathione peroxidase activity and mRNA levels but normal liver selenium levels. J Nutr Biochem 1992;3:429-436.
80. Olin KL, Walter RM, Keen CL: Copper deficiency affects selenoglutathione peroxidase and selenodiodinase activities and antioxidant defense in weanling rats. Am J Clin Nutr 1994;59:654-658.
81. Lukaski HC, Hall CB, Marchello MJ: Body temperature and thyroid hormone metabolism of copper-deficient rats. J Nutr Biochem 1995;6:445-451.
82. Harris ED: The iron-copper connection: The link to ceruloplasmin grows stronger. Nutr Rev 1996; 53:170-173.
83. Chen Y, Saari JT, Kong YJ: Weak antioxidant defenses make the heart a target for damage in copper-deficient rats. Free Radic Biol Med 1994;17:529-536.
84. Kim S, Chao PY, Allen KGD: Inhibition of elevated hepatic glutathione abolishes copper deficiency cholesterolemia. FASEB J 1992;6:2467-2471.
85. Ziegler DM: Role of reversible oxidation-reduction of enzyme thiols-disulfides in metabolic regulation. Annu Rev Biochem 1985;54:305-329.
86. Lynch SM, Strain JJ: Effects of copper deficiency on hepatic and cardiac antioxidant enzyme activities in lactose- and sucrose-fed rats. Br J Nutr 1989;61:345-354.
87. Kletzien RF, Harris PKW, Foellmi LA: Glucose-6-phosphate dehydrogenase: A 'housekeeping' enzyme subject to tissue-specific regulation of hormones, nutrients and oxidant stress. FASEB J 1994;8:174-181.
88. Rayssiguier Y, Gueux E, Bussière L, Mazur A: Copper deficiency increases the susceptibility of lipoproteins and tissues to peroxidation in rats. J Nutr 1993;23:1343-1348.
89. Reiser K, McCormick RJ, Rucker RB: Enzymatic and nonenzymatic cross-linking of collagen and elastin. FASEB J 1992;6:2439-2449.
90. Schuschke DA, Saari JT, Miller FN: A role for dietary copper in nitric-oxide mediated vasodilation. Microcirculation 1995;2:371-376.
91. Candipan RC, Wang B-Y, Buitrago R, Tsao PS, Cooke JP: Regression or progression: Dependency on vascular nitric oxide. Arterioscler Thromb Vase Biol 1996;16:44-50.
92. Salvemini D, Currie MG, Mollace W: Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators. J Clin Invest 1996;97:2562-2568.
93. Lominadze DG, Saari JT, Miller FN, Catalgamo JL, Justus DE, Schuschke DA: Platelet aggregation and adhesion during dietary copper deficiency in rats. Thromb Haemost 1996;75:630-634.
94. Morin CL, Allen KGD, Mathias M: Thromboxane production in coper-deficient and marginal platelets: Influence of superoxide dismutase and lipid hydroperoxides. Proc Soc Exp Biol Med 1993; 202:167-173.
95. Johnson WT, Dufault SN, Newman SM Jr: Altered nucleotide content and changes in mitochondrial energy states associated with copper deficiency in rat platelets. J Nutr Biochem 1995;6:551-556.
96. Schuschke LA, Saari JT, Miller FN, Schuschke DA: Hemostatic mechanisms in marginally copper-deficient rats. J Lab Clin Med 1995;125:748-753.
97. Lynch SM, Klevay LM: Effect of a dietary copper deficiency on plasma coagulation factor activities in male and female mice. J Nutr Biochem 1992;3:387-391.
98. Cushman M, Yanez D, Psaty BM, Fried LP, Heiss G, Lee M, Polak JF, Savage PJ, Tracy RP: Association of fibrinogen and coagulation factors VII and VIII with cardiovascular risk factors in the elderly. Am J Epidemiol 1996;143:665-676.
99. Klevay LM, Pond WG, Medeiros DM: Decreased high density lipoprotein cholesterol and apoprotein A-I in plasma and ultrastructural pathology in cardiac muscle of young pigs fed a diet high in zinc. Nutr Res 1994;14:1227-1239.
100. Wildman RFC, Medeiros DM, McCoy E: Cardiac changes with dietary copper, iron or selenium restriction: Organelle and basal laminae aberrations, decreased ventricular function and altered gross morphometry. J Trace Elem Exp Med 1995;8:11-27.
101. Liao Z, Medeiros DM, McClune SA, Prochaska LJ: Cardiac levels of fibronectin, laminin, isomyosins, and cytochrome c oxidase of weanling rats are more vulnerable to copper deficiency than those of postweanling rats. J Nutr Biochem 1995;6:385-391.
102. Matz JM, Saari JT, Bode AM: Functional aspects of oxidative phosphorylation and electron transport in cardiac mitochondria of copper-deficient rats. J Nutr Biochem 1995;6:644-652.
103. Kuang W-H, Lai C-C, Wang Y, Klevay LM, Askari A, Chiu TH: Altered expressions of cardiac Na/K-ATPase isoforms in copper deficient rats. Cardiovasc Res 1995;29:563-568.
104. Danks DM: Copper deficiency in humans. Ann Rev Nutr 1988;8:235-257.